Silence Therapeutics launches public offering of $150M ADS Silence Therapeutics has launched an underwritten public offering of about $150M of its American Depositary Shares (ADSs) in the United States. Each ADS represents three ordinary shares of the company.
Silence Therapeutics launches public offering of $150M ADS
Silence Therapeutics has launched an underwritten public offering of about $150M of its American Depositary Shares (ADSs) in the United States.
Each ADS represents three ordinary shares of the company.
The company also intends to grant underwriters certain rights to purchase additional ADSs.
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.
